Pear Therapeutics, Inc. Class A Common Stock

Go to Pear Therapeutics, Inc. Class A Common Stock Website

$0.03

(%)
Live
Previous Close

$0.0292

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional investors at $2.48 per share. Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares gained 108% to $3.29 after jumping 25% on Monday. BELLUS Health Inc. (NASDAQ: BLU) shares jumped 99.5% to $14.48 after GSK announced it will acquire the company for $14.75 per share in cash, representing an approximate total equity value of $2 billion. SAB Biotherapeutics, Inc. (NASDAQ: SABS) rose 79% to $1.38. The FDA granted Breakthrough Therapy Designation (BTD) to SAB Biotherapeutics SAB-176, an investigational therapy for post-exposure prophylaxis for Type A and Type B influenza illness in high-risk patients, including antiviral resistant strains. HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) gained 57.7% to $4.73 after the company reported key first quarter milestone achievements for drug discovery. Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 55% to $1.84. Super League Gaming, Inc. (NASDAQ: SLGG) surged 39% to $0.5949 after the company and LandVault announced a strategic partnership to provide brands with scalable solutions to bridge the gap between Web2 and Web3. Phio Pharmaceuticals Corp. (NASDAQ: PHIO) rose 38.3% to $8.13. Phio presented preclinical data showing synergy-enhanced in vivo anti-tumor efficacy of PD-1/CTLA-4 dual-targeting INTASYL. Gamida Cell Ltd. (NASDAQ: GMDA) climbed 33% to $1.49 after the U.S. Food and Drug Administration approved Gamida Cell’s allogeneic cell therapy, Omisirge® (omidubicel-onlv). Toro Corp. (NASDAQ: TORO) gained 29.4% to $4.2344. YS Biopharma Co., Ltd. (NASDAQ: YS) gained 26% to $1.99 after the company reported preliminary total revenue of $103 million, representing a year-over-year growth of 30%. Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) shares gained 25% to $4.8212. Trevi Therapeutics, Inc. (NASDAQ:

Related tickers: MRUS, RLAY, WINT, KRBP, BLBX, PTPI, BBBY, CLSK, EVAX, ERIC, CYTO, LIDR, PRST, RIOT, DBGI, BLU, LEV, TPST, LZ, GMDA, DRMA, CJJD, PHIO, SABS, NOTE, SLGG, ALLR, TORO, UIHC, TRVI, PEAR, ANGN, AXLA, AIU, CFRX, CNSP, KWE, BLCM, GSMG, YS, HTGM, SBSW, SDIG, OBLG.

Read Full Article

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. Blackboxstocks Inc. (NASDAQ: BLBX) shares jumped 147.5% to $6.55 after the company announced it entered a letter of intent to merge with Evtec. Presto Automation Inc. (NASDAQ: PRST) jumped 114% to $3.00. Presto recently promoted Dan Mosher to President and Xavier Casanova to Chief Operating Officer. Windtree Therapeutics, Inc. (NASDAQ: WINT) gained 97% to $8.53. Windtree Therapeutics announced issuance of patent from European Patent Office for Dual Mechanism SERCA2a Activator. Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) jumped 94% to $1.28 after the company announced that it entered a definitive agreement to be acquired by Shin Nippon Biomedical Laboratories for $0.91 per share in cash. Prometheus Biosciences, Inc. (NASDAQ: RXDX) gained 69.5% to $193.20 after Merck announced it will acquire the company for $200 per share in cash. CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) shares gained 62.3% to $3.8150 after CEO John M Climaco reported the purchase of 15,000 shares at an average price of $0.69 per share and Director Jerzy Gumulka reported the purchase of 7,173 shares at an average price of $0.74 per share. NextPlay Technologies, Inc. (NASDAQ: NXTP) rose 30.3% to $1.70 after gaining more than 10% on Friday. KWESST Micro Systems Inc. (NASDAQ: KWE) gained 28.4% to $3.3504 after gaining more than 17% on Friday. Kiromic BioPharma, Inc. (NASDAQ: KRBP) surged 26.8% to $5.91. Creative Media & Community Trust Corporation (NASDAQ: CMCT) rose 27% to $5.44. Daniel M. Negari proposed to acquire all of the outstanding shares of the issuer for $8.88 per share in cash in an amended 13D filing. Marker Therapeutics, Inc. (NASDAQ: MRKR) gained 20.9% to ...

Related tickers: CNSP, LASE, MCRB, MRNA, DFLI, EDIT, OBLG, LXRX, KWE, LIVN, PCVX, NCMI, CXAI, BTCY, RXT, PRST, SMX, WINT, XPEV, STSA, PKST, BLBX, KRBP, WLFC, INPX, RBLX, SAI, VS, PTPI, STT, BNGO, IBRX, MANU, ALLK, REVB, NXTP, RAPT, MRKR, MRAI, RXDX, RCLF, ALLR, CFRX, IDEX, PEAR, VAPO, MORF, JFBR, NIR, POAI, NOGN, CMCT.

Read Full Article
Trending Tickers

Please sign in to view